Inventor · disambiguated record
Franck Alexandre Silva
Also filed as: SILVA FRANCK A · SILVA FRANCK ALEXANDRE
20 granted patents·3 pending applications·164 citations·filing 2009–2021
95Inventor score
Top patents by PatentIndex Score
23 records- 0193US9200007B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsSHUTTLEWORTH STEPHEN JOSEPH·Filed 2010·Granted Dec 1, 2015·22 cites·6 claims
- 0292US11708378B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsCONVALIFE SHANGHAI CO LTD·Filed 2021·Granted Jul 25, 2023·2 cites·11 claims
- 0392US9981987B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2015·Granted May 29, 2018·11 cites·14 claims
- 0492US8981087B2Benzo [E] [1,3] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitorsSHUTTLEWORTH STEPHEN JOSEPH·Filed 2010·Granted Mar 17, 2015·26 cites·11 claims
- 0591US10035785B2Phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2017·Granted Jul 31, 2018·10 cites·17 claims
- 0691US9580442B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2015·Granted Feb 28, 2017·14 cites·5 claims
- 0791US9266879B2Naphthridine derivatives as PI3K inhibitors for the treatment of cancer and immune-inflammatory diseaseSHUTTLEWORTH STEPHEN JOSEPH·Filed 2011·Granted Feb 23, 2016·21 cites·13 claims
- 0890US9938290B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2017·Granted Apr 10, 2018·11 cites·3 claims
- 0989US9663487B2Phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2013·Granted May 30, 2017·13 cites·15 claims
- 1088US10513530B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2018·Granted Dec 24, 2019·5 cites·19 claims
- 1188US10501478B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2018·Granted Dec 10, 2019·5 cites·7 claims
- 1286US11779586B2Compounds comprising tricyclic heterocyclic compoundsCONVALIFE SHANGHAI CO LTD·Filed 2020·Granted Oct 10, 2023·2 cites·12 claims
- 1382US10377764B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2016·Granted Aug 13, 2019·5 cites·2 claims
- 1481US10442815B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2016·Granted Oct 15, 2019·5 cites·20 claims
- 1581US10150763B2Histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2017·Granted Dec 11, 2018·3 cites·16 claims
- 1680US9862685B2Histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2014·Granted Jan 9, 2018·4 cites·12 claims
- 1779US9676765B2Histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2013·Granted Jun 13, 2017·4 cites·8 claims
- 1870US2020354378A1Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1967US10533003B2Polyheteroarl histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2015·Granted Jan 14, 2020·1 cites·7 claims
- 2062US10870624B2Histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2017·Granted Dec 22, 2020·0 cites·5 claims
- 2152US8614193B2Depsipeptides and their therapeutic useSHUTTLEWORTH STEPHEN JOSEPH·Filed 2009·Granted Dec 24, 2013·0 cites·15 claims
- 2249US2021038607A1Oxadiazolylthiophene derivatives useful as histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2345US2018235974A1Compounds comprising tricyclic heterocyclic compoundsKARUS THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Franck Alexandre Silva files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →